Clinical Trials Browser

Phase 3 × Leiomyosarcoma × anlotinib × Clear all

NCT03016819 2026-02-25

APROMISS

Phase 3 Recruiting

Leiomyosarcoma, Sarcoma, Sarcoma, Synovial, Sarcoma, Alveolar Soft Part